Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
My Lists

Compugen  (Stock symbol: CGEN )

560 S. Winchester Blvd., Suite 500
San Jose, CA 95128
(408) 236-7336
Website Company Summary Management Team

Management: Alex Kotzer (President/CEO);  Erez Chimovits (President);  Eran Aharonson (VP R&D);  Noam Shani (VP R&D);  D'vorah Graeser (VP Intellectual Property);  Ronit Weinstein (VP HR)
Outside board: Orna Berry (Gemini Israel Venture Funds);  David Schlachet (Biocom Management and Investments Managing Partner);  Martin Gerstel (Compugen Chairman);  Ruben Krupik (Arison Technologies President/CEO)

Business description: Compugen, a genomics-based drug and diagnostic discovery company, increases the probability of successful development of novel drug and diagnostic products by incorporating ideas and methods from mathematics, computer science, and physics into the disciplines of biology, organic chemistry, and medicine. This unique capability results in powerful predictive models and discovery engines, which are both advancing the understanding of important biological phenomena and enabling the discovery of numerous potential therapeutic products and diagnostic markers. The Company has an early-stage in-house pipeline consisting of selected therapeutic protein candidates discovered by the Company; additional discoveries have been out-licensed for development. Among Compugen's customers and partners are leading pharmaceutical and diagnostic companies, such as Abbott Laboratories, Diagnostic Products Corporation, Novartis, and Pfizer.
Partners include: Abbott Laboratories NovartisPfizer ;  Biosite Diagnostics;  Diagnostic Products Corporation;  Millennium Pharmaceuticals ;  MultiGene Vascular Systems;  Ortho-Clinical Diagnostics;  Sigma-Genosys

Rounds: 1
Ownership: Public  
Stock Symbol: CGEN

Last Tweets


Last Mentions

Sector: Biotech
Year Founded: 1993
Rounds: 1
Ownership: Public  
Stock Symbol: CGEN